CIK 0001853816 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Dermata Therapeutics, Inc.
Sign in to watch- Ticker
- DRMA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (858)-223-0882
- Business address
- 3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO, CA, 92130
- Former names
- Dermata Therapeutics, Inc.
- 3 Insider Initial Statement of Ownership
- 424B3 Offering Prospectus
- 8-K Event Executive or director change · Regulation FD disclosure
- SC 13D Stake Beneficial Ownership Report
- SC 13D Stake Beneficial Ownership Report
- 4 Derivatives Options or other derivatives
- 4 Conversion Senior Vice President acquired 64,631 shares (conversion)
- 4 Open-market buy Director bought 35,714 shares
- 4 Conversion 10% owner acquired 1,988,227 shares (conversion)
- 4 Derivatives Options or other derivatives
- 4 Conversion Director acquired 8,163 shares (conversion)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Conversion Chief Financial Officer acquired 4,581 shares (conversion)
- 4 Conversion Senior VP, Development acquired 2,439 shares (conversion)
- 4 Open-market buy President, CEO and Chairman bought 152,857 shares at $4.96 ($49,631)
- 424B4 Offering Prospectus
- POS EX Other Post-effective Amendment
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- EFFECT Other Notice of Effectiveness
Page 17 of 19 · 373 filings